-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Market analysis of chemical machinery equipment network ] May 18 news, the domestic pharmaceutical machinery giant Chutian Technology accepted the investigation of 4 institutions.
In this exchange activity, the company introduced the industry that the organization is more concerned about, and mentioned that the market size of the pharmaceutical equipment industry is 50 to 60 billion.
The company believes that with the intensification of my country's population aging and the gradual improvement in the level of drug use among urban and rural residents and the narrowing of the gap, the demand for drugs is estimated to maintain a relatively high rate of growth.
At the same time, the epidemic has brought about an increase in market demand for pharmaceutical equipment.
It is expected that orders for related products will continue this year and next.
Chemical machinery and equipment network market analysis chemical machinery and equipmentIn this exchange activity, the company introduced the industry that the organization is more concerned about, and mentioned that the market size of the pharmaceutical equipment industry is 50 to 60 billion.
The company believes that with the intensification of my country's population aging and the gradual improvement in the level of drug use among urban and rural residents and the narrowing of the gap, the demand for drugs is estimated to maintain a relatively high rate of growth.
At the same time, the epidemic has brought about an increase in market demand for pharmaceutical equipment.
It is expected that orders for related products will continue this year and next.
In addition, foreign imported equipment cannot meet the delivery time and service timeliness requirements of domestic pharmaceutical companies, and the quality of domestic equipment is improving and the delivery cycle is guaranteed.
This has led to changes in customers' selection of equipment suppliers, from preferring imports to choosing domestic substitutes.
.
In this regard, Chutian said that taking this opportunity to cut into the supply chain system of the high-end pharmaceutical market, it is more optimistic about the growth brought by this related stock market.
This has led to changes in customers' selection of equipment suppliers, from preferring imports to choosing domestic substitutes.
.
In this regard, Chutian said that taking this opportunity to cut into the supply chain system of the high-end pharmaceutical market, it is more optimistic about the growth brought by this related stock market.
The actions of giant companies are worthy of attention and often represent new development trends in the industry.
Several important information can be extracted from the above content.
First, the demand for pharmaceutical equipment may continue to grow this year and next, and the industry has development opportunities; second, the domestic substitution process will accelerate, and the industry needs to transform from the low-end to the high-end.
For pharmaceutical equipment companies, while seizing opportunities, they should face challenges and make breakthroughs in order to achieve better development.
Several important information can be extracted from the above content.
First, the demand for pharmaceutical equipment may continue to grow this year and next, and the industry has development opportunities; second, the domestic substitution process will accelerate, and the industry needs to transform from the low-end to the high-end.
For pharmaceutical equipment companies, while seizing opportunities, they should face challenges and make breakthroughs in order to achieve better development.
challenge
challenge The market space for domestically produced pharmaceutical equipment to replace imports is worthy of recognition, but at present, my country's high-end pharmaceutical equipment market is still dominated by imported products, and the competitiveness of domestically produced pharmaceutical equipment is weak.
There are several main reasons behind this.
On the one hand, domestic pharmaceutical machinery companies are mainly small and medium-sized, with weak innovation capabilities, technical levels, and financial strength.
The products they build are mostly concentrated in the low-end and low-end areas, and they are generally lacking in the high-end areas.
There is also a lack of competitive domestic high-end pharmaceutical machinery companies with high-end equipment that meets the application requirements.
On the one hand, domestic pharmaceutical machinery companies are mainly small and medium-sized, with weak innovation capabilities, technical levels, and financial strength.
The products they build are mostly concentrated in the low-end and low-end areas, and they are generally lacking in the high-end areas.
There is also a lack of competitive domestic high-end pharmaceutical machinery companies with high-end equipment that meets the application requirements.
On the other hand, for a long time, many domestic pharmaceutical machines have problems such as poor quality and low stability.
Users have left a poor user experience with this, and then over-relied on or "blindly worshiped" imported equipment.
In recent years, although domestic pharmaceutical companies have made continuous efforts, most of them have weak brand influence and are difficult to open the market like imported products.
This has also caused some small and medium-sized enterprises to retreat.
They are not very enthusiastic about research and development and are unwilling to spend time on high-end products.
effort.
Users have left a poor user experience with this, and then over-relied on or "blindly worshiped" imported equipment.
In recent years, although domestic pharmaceutical companies have made continuous efforts, most of them have weak brand influence and are difficult to open the market like imported products.
This has also caused some small and medium-sized enterprises to retreat.
They are not very enthusiastic about research and development and are unwilling to spend time on high-end products.
effort.
Countermeasure
Countermeasure In response to the lack of core technologies, domestic pharmaceutical companies need to strengthen R&D investment, pay attention to the introduction of talents, continuously improve their independent innovation capabilities, solve the problem of key core technologies being "stuck", and actively take measures to develop under the background of the country's vigorous promotion of scientific and technological innovation.
Domestic technology with independent intellectual property rights.
Domestic technology with independent intellectual property rights.
In response to users’ deep-rooted and weak impressions of domestically-produced pharmaceutical machines, more practical policy support is needed to encourage domestic substitution of imports, and at the same time it can play a demonstrative role for high-end users; on the other hand, companies need to ensure reliable product quality under the premise , Improve brand influence and establish market reputation.
Conclusion
Conclusion Generally speaking, driven by policy dividends and the market, pharmaceutical equipment, especially high-end pharmaceutical equipment, has considerable room for growth.
Under the trend of accelerating domestic substitution process, pharmaceutical machinery companies need to grasp market development opportunities and pay more attention Talent, technology, R&D, innovation and other aspects are transforming and upgrading towards high-end areas.
Pharmaceutical equipmentUnder the trend of accelerating domestic substitution process, pharmaceutical machinery companies need to grasp market development opportunities and pay more attention Talent, technology, R&D, innovation and other aspects are transforming and upgrading towards high-end areas.
Original title: Demand for pharmaceutical equipment may continue to grow this year and next, and the process of domestic substitution will accelerate
